219 related articles for article (PubMed ID: 34689357)
1. The diagnostic protocol for hereditary spherocytosis-2021 update.
Wu Y; Liao L; Lin F
J Clin Lab Anal; 2021 Dec; 35(12):e24034. PubMed ID: 34689357
[TBL] [Abstract][Full Text] [Related]
2. Mean reticulocyte volume: a specific parameter to screen for hereditary spherocytosis.
Xu Y; Yang W; Liao L; Deng Z; Qiu Y; Chen W; Lin F
Eur J Haematol; 2016 Feb; 96(2):170-4. PubMed ID: 25868528
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of mean sphered corpuscular volume for predicting hereditary spherocytosis.
Broséus J; Visomblain B; Guy J; Maynadié M; Girodon F
Int J Lab Hematol; 2010 Oct; 32(5):519-23. PubMed ID: 20136849
[TBL] [Abstract][Full Text] [Related]
4. Blood cell parameters for screening and diagnosis of hereditary spherocytosis.
Liao L; Xu Y; Wei H; Qiu Y; Chen W; Huang J; Tao Y; Deng X; Deng Z; Tao H; Lin F
J Clin Lab Anal; 2019 May; 33(4):e22844. PubMed ID: 30945356
[TBL] [Abstract][Full Text] [Related]
5. Utility of mean sphered cell volume and mean reticulocyte volume for the diagnosis of hereditary spherocytosis.
Arora RD; Dass J; Maydeo S; Arya V; Kotwal J; Bhargava M
Hematology; 2018 Aug; 23(7):413-416. PubMed ID: 29338606
[TBL] [Abstract][Full Text] [Related]
6. Mean reticulocyte volume enhances the utility of red cell mean sphered cell volume in differentiating peripheral blood spherocytes of hereditary spherocytosis from other causes.
Nair SC; Arora N; Jain S; Inbakumar D; Mammen J; Sitaram U
Indian J Pathol Microbiol; 2015; 58(3):307-9. PubMed ID: 26275251
[TBL] [Abstract][Full Text] [Related]
7. Values of mean cell volume and mean sphered cell volume can differentiate hereditary spherocytosis and thalassemia.
Liao L; Deng ZF; Qiu YL; Chen P; Chen WQ; Lin FQ
Hematology; 2014 Oct; 19(7):393-6. PubMed ID: 24620949
[TBL] [Abstract][Full Text] [Related]
8. Misdiagnosis of two cases of hereditary spherocytosis in a family and review of published reports.
Deng Z; Liao L; Yang W; Lin F
Clin Chim Acta; 2015 Feb; 441():6-9. PubMed ID: 25485852
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of eosin-5-maleimide flow cytometric test in diagnosis of hereditary spherocytosis.
Kar R; Mishra P; Pati HP
Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):8-16. PubMed ID: 18782334
[TBL] [Abstract][Full Text] [Related]
10. Temporal differences in membrane loss lead to distinct reticulocyte features in hereditary spherocytosis and in immune hemolytic anemia.
Da Costa L; Mohandas N; Sorette M; Grange MJ; Tchernia G; Cynober T
Blood; 2001 Nov; 98(10):2894-9. PubMed ID: 11698268
[TBL] [Abstract][Full Text] [Related]
11. Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders.
Kedar PS; Colah RB; Kulkarni S; Ghosh K; Mohanty D
Clin Lab Haematol; 2003 Dec; 25(6):373-6. PubMed ID: 14641141
[TBL] [Abstract][Full Text] [Related]
12. Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis.
King MJ; Telfer P; MacKinnon H; Langabeer L; McMahon C; Darbyshire P; Dhermy D
Cytometry B Clin Cytom; 2008 Jul; 74(4):244-50. PubMed ID: 18454487
[TBL] [Abstract][Full Text] [Related]
13. Comparison study of the eosin-5'-maleimide binding test, flow cytometric osmotic fragility test, and cryohemolysis test in the diagnosis of hereditary spherocytosis.
Park SH; Park CJ; Lee BR; Cho YU; Jang S; Kim N; Koh KN; Im HJ; Seo JJ; Park ES; Lee JW; Yoo KH; Jung HL
Am J Clin Pathol; 2014 Oct; 142(4):474-84. PubMed ID: 25239414
[TBL] [Abstract][Full Text] [Related]
14. Genetic mutation analysis of hereditary spherocytosis in Guangxi Zhuang Autonomous Region.
Chen X; Liao L; Wu Y; Xiang L; Qin Y; Luo M; Lin F
J Hematop; 2023 Jun; 16(2):95-101. PubMed ID: 38175446
[TBL] [Abstract][Full Text] [Related]
15. A comparative evaluation of Eosin-5'-maleimide flow cytometry reveals a high diagnostic efficacy for hereditary spherocytosis.
Joshi P; Aggarwal A; Jamwal M; Sachdeva MU; Bansal D; Malhotra P; Sharma P; Das R
Int J Lab Hematol; 2016 Oct; 38(5):520-6. PubMed ID: 27339613
[TBL] [Abstract][Full Text] [Related]
16. Biochemical, Cellular, and Proteomic Characterization of Hereditary Spherocytosis Among Tunisians.
Trabelsi N; Bouguerra G; Haddad F; Ouederni M; Darragi I; Boudrigua I; Chaouachi D; Barmat M; Fouzai C; Bejaoui M; Menif S; Kraiem I; Abbes S
Cell Physiol Biochem; 2021 Mar; 55(1):117-129. PubMed ID: 33667330
[TBL] [Abstract][Full Text] [Related]
17. Rapid flow cytometric test using eosin-5-maleimide for diagnosis of red blood cell membrane disorders.
Tachavanich K; Tanphaichitr VS; Utto W; Viprakasit V
Southeast Asian J Trop Med Public Health; 2009 May; 40(3):570-5. PubMed ID: 19842445
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometry as a diagnostic tool for hereditary spherocytosis.
Stoya G; Gruhn B; Vogelsang H; Baumann E; Linss W
Acta Haematol; 2006; 116(3):186-91. PubMed ID: 17016037
[TBL] [Abstract][Full Text] [Related]
19. Automated reticulocyte parameters for hereditary spherocytosis screening.
Lazarova E; Pradier O; Cotton F; Gulbis B
Ann Hematol; 2014 Nov; 93(11):1809-18. PubMed ID: 24912770
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric osmotic fragility test and eosin-5'-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis.
Arora RD; Dass J; Maydeo S; Arya V; Radhakrishnan N; Sachdeva A; Kotwal J; Bhargava M
Int J Lab Hematol; 2018 Jun; 40(3):335-342. PubMed ID: 29573337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
